Endogenous estradiol may influence IGF-I levels in acromegalic women treated with pegvisomant

Author： Roemmler J.   Bidlingmaier M.   Schopohl J.  

Publisher： Springer Publishing Company

ISSN： 1386-341X

Source： Pituitary, Vol.13, Iss.1, 2010-03, pp. : 89-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum IGF-I levels in the diagnosis and monitoring of acromegaly

By Brooke A.   Drake W.  

Pituitary, Vol. 10, Iss. 2, 2007-06 ,pp. : 173-179

Springer Publishing Company

Access to resources Recommend Favorite

Normal levels of serum IGF-I: determinants and validity of current reference ranges

By Brabant G.   Wallaschofski H.  

Pituitary, Vol. 10, Iss. 2, 2007-06 ,pp. : 129-133

Springer Publishing Company

Access to resources Recommend Favorite

Pituitary Function and IGF-I Levels following Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 31, Iss. 2, 2010-12 ,pp. : 163-169

Karger

Access to resources Recommend Favorite

Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia

By Kleinberg David  

Pituitary, Vol. 14, Iss. 1, 2011-03 ,pp. : 44-52

Springer Publishing Company

Access to resources Recommend Favorite

Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients

By Jehle P.M.   Schulten K.   Schulz W.   Jehle D.R.   Stracke S.   Manfras B.   Boehm B.O.   Baylink D.J.   Mohan S.  

European Journal of Internal Medicine, Vol. 14, Iss. 1, 2003-02 ,pp. : 32-38

Elsevier

Access to resources Recommend Favorite